The U.S. Centers for Disease Control and Prevention (CDC) today published updated vaccination recommendations for ages 18 years or younger.
Published on November 17, 2023, the 2024 Immunization Schedule is effective immediately.
The CDC's Advisory Committee on Immunization Practices (ACIP) has approved these vaccine recommendations by majority vote since October 26, 2023.
The ACIP develops recommendations for U.S. immunizations, including ages when vaccines should be given, number of doses, time between doses, and precautions and contraindications.
Updated 2024 Children Vaccination Schedule Effective Immediately
Updated 2024 Children Vaccination Schedule Effective Immediately
The U.S. Centers for Disease Control and Prevention (CDC) today published updated vaccination recommendations for ages 18 years or younger.
Published on November 17, 2023, the 2024 Immunization Schedule is effective immediately.
The CDC's Advisory Committee on Immunization Practices (ACIP) has approved these vaccine recommendations by majority vote since October 26, 2023.
The ACIP develops recommendations for U.S. immunizations, including ages when vaccines should be given, number of doses, time between doses, and precautions and contraindications.
Measles Vaccination Coverage Still Below Prepandemic Levels
Coverage with first dose of measles-containing vaccine decreased to 81 percent in 2021 during pandemic
Measles Vaccination Has Averted 57 Million Deaths Since 2000
Coverage with first dose of measles-containing vaccine decreased to 81 percent in 2021 during pandemic
Chickenpox Vaccination Recommended in England
Vaccine experts in the United Kingdom recommended expanding its children's vaccination program to better align with other developed countries.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended adding a vaccine against varicella, known as chickenpox, to the U.K.'s routine childhood immunization program.
The vaccine would be offered to all toddlers in two doses, using the combined MMRV (measles, mumps, rubella, and varicella) vaccine.
Olfactory, Gustatory Dysfunction Decline in Years Following COVID-19
Three years after COVID-19, no significant excess of olfactory or gustatory dysfunction seen in cases versus controls
Preexisting Allergic Disease May Increase Risk for Long COVID
Systematic literature review identifies increased risk but with very low certainty
For Teens, Protection Against SARS-CoV-2 Highest for Hybrid Immunity
Protection highest for students with immunity from previous infection and three doses of vaccination
Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir
Virologic rebound more common among those who started therapy within two days of symptom onset
Burnout on the Rise Among Anesthesiologists Since Pandemic
Lack of support at work and staffing shortages increase risk for burnout